Company / Financials
CHAMPIONS ONCOLOGY, INC. Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$50.2M
FY2025 · -11.9% YoY
Net Income
-$7.3M
FY2025 · -254.8% YoY
Profit Margin
-14.5%
FY2025 · net income / revenue
ROE
-192.9%
FY2025 · return on equity
Total Assets
$32.3M
FY2025
Total Debt
-
FY2025
Equity
$3.8M
FY2025
ROA
-22.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$50.2M-11.9% YoYNet Income HistoryProfit after all expenses and taxes-$7.3M-254.8% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$29.4M+3.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$7.4M-261.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$11.1M+18.5% YoYR&D Expense HistoryResearch and development spending$9.5M+39.8% YoYIncome Tax HistoryTotal income tax expense-$32.0K+57.3% YoYEPS (Basic) HistoryBasic earnings per share-$0.54-38.5% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.54-38.5% YoYShares Outstanding HistoryWeighted average diluted shares outstanding13.6M+0.4% YoY